<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38979040</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>Influence of non-pharmaceutical interventions during the COVID-19 pandemic on respiratory viral infections - a prospective population-based cohort study.</ArticleTitle><Pagination><StartPage>1415778</StartPage><MedlinePgn>1415778</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1415778</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2024.1415778</ELocationID><Abstract><AbstractText Label="UNLABELLED">Non-pharmaceutical interventions (NPI) have been proven successful in a population-based approach to protect from SARS-CoV-2 transmission during the COVID-19 pandemic. As a consequential-effect, a reduction in the spread of all respiratory viruses has been observed, but the primary factors behind this phenomenon have yet to be identified. We conducted a subgroup analysis of participants from the ELISA study, a prospective longitudinal cohort study on SARS-CoV-2 transmission, at four timepoints from November 2020 - September 2022. The aim was to provide a detailed overview of the circulation of respiratory viruses over 2 years and to identify potential personal risk factors of virus distribution. All participants were screened using qPCR for respiratory viral infections from nasopharyngeal swabs and answered a questionnaire regarding behavioral factors. Several categories of risk factors for the transmission of respiratory viruses were evaluated using a scoring system. In total, 1,124 participants were included in the study, showing high adherence to governmental-introduced NPI. The overall number of respiratory virus infections was low (0-4.9% of participants), with adenovirus (1.7%), rhino-/enterovirus (3.2%) and SARS-CoV-2 (1.2%) being the most abundant. We detected an inverse correlation between the number and intensity of NPI and the number of detected respiratory viruses. More precisely, the attendance of social events and household size was associated with rhino-/enterovirus infection while social contacts were associated with being positive for any virus. NPI introduced during the COVID-19 pandemic reduced the occurrence of seasonal respiratory viruses in our study, showing different risk-factors for enhanced transmission between viruses.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="UNASSIGNED">DRKS.de, German Clinical Trials Register (DRKS), Identifier: DRKS00023418, Registered on 28 October 2020.</AbstractText><CopyrightInformation>Copyright © 2024 Käding, Waldeck, Meier, Boutin, Borsche, Balck, Föh, Kramer, Klein, Katalinic and Rupp.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Käding</LastName><ForeName>Nadja</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein, Lübeck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Waldeck</LastName><ForeName>Frederike</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein, Lübeck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meier</LastName><ForeName>Bjarne</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein, Lübeck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boutin</LastName><ForeName>Sébastien</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein, Lübeck, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Lübeck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borsche</LastName><ForeName>Max</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balck</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Föh</LastName><ForeName>Bandik</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Medicine I, University Hospital Schleswig-Holstein, Lübeck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kramer</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>LADR Laboratory Group Dr. Kramer and Colleagues, Geesthacht, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katalinic</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Social Medicine and Epidemiology, University of Lübeck, Lübeck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rupp</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein, Lübeck, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000085762" MajorTopicYN="N">Physical Distancing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">behavioral factors</Keyword><Keyword MajorTopicYN="N">infection risk</Keyword><Keyword MajorTopicYN="N">non-pharmaceutical interventions</Keyword><Keyword MajorTopicYN="N">respiratory viruses</Keyword><Keyword MajorTopicYN="N">virus distribution</Keyword></KeywordList><CoiStatement>Author JK is employed by LADR GmbH, Germany. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>9</Day><Hour>4</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38979040</ArticleId><ArticleId IdType="pmc">PMC11228307</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2024.1415778</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization . Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza. (2019). Available at:
https://iris.who.int/bitstream/handle/10665/329438/9789241516839-eng.pdf?sequence=1</Citation></Reference><Reference><Citation>Rehfuess EA, Movsisyan A, Pfadenhauer LM, Burns J, Ludolph R, Michie S, et al. . Public health and social measures during health emergencies such as the COVID-19 pandemic: an initial framework to conceptualize and classify measures. Influenza Other Respir Viruses. (2023) 17:e13110. doi: 10.1111/irv.13110, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.13110</ArticleId><ArticleId IdType="pmc">PMC9996427</ArticleId><ArticleId IdType="pubmed">36909296</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, et al. . The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. (2020) 395:912–20. doi: 10.1016/S0140-6736(20)30460-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30460-8</ArticleId><ArticleId IdType="pmc">PMC7158942</ArticleId><ArticleId IdType="pubmed">32112714</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiliopoulos L. On the effectiveness of COVID-19 restrictions and lockdowns: Pan metron ariston. BMC Public Health. (2022) 22:1842. doi: 10.1186/s12889-022-14177-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-022-14177-7</ArticleId><ArticleId IdType="pmc">PMC9526209</ArticleId><ArticleId IdType="pubmed">36183075</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi HJ, Kim NY, Eom SA, Kim-Jeon MD, Oh SS, Moon BS, et al. . Effects of non-pharmacological interventions on respiratory viruses other than SARS-CoV-2: analysis of laboratory surveillance and literature review from 2018 to 2021. J Korean Med Sci. (2022) 37:e172. doi: 10.3346/jkms.2022.37.e172</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2022.37.e172</ArticleId><ArticleId IdType="pmc">PMC9151990</ArticleId><ArticleId IdType="pubmed">35638198</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez-Brito A, El Bcheraoui C, Pozo-Martin F. Systematic review of empirical studies comparing the effectiveness of non-pharmaceutical interventions against COVID-19. J Infect. (2021) 83:281–93. doi: 10.1016/j.jinf.2021.06.018, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.06.018</ArticleId><ArticleId IdType="pmc">PMC8214911</ArticleId><ArticleId IdType="pubmed">34161818</ArticleId></ArticleIdList></Reference><Reference><Citation>Schleswig-Holstein, Ministerium Für Soziales, Gesundheit, Jugend, Familie und Senioren , Eds. Landesverordnung über Maßnahmen zur Bekämpfung der Ausbreitung des neuartigen Coronavirus SARS-CoV-2 in Schleswig-Holstein (SARS-CoV-2-Bekämpfungsverordnung – SARS-CoV-2-BekämpfV). (2020). Available at:
https://transparenz.schleswig-holstein.de/dataset/41553002-13e9-467d-ba09-ab4a51542a7e/resource/f5175282-f2f2-4a9a-8790-d2d533a13d25/download/sars-cov-2-bekampfungsvo3810690577184248626.pdf</Citation></Reference><Reference><Citation>Ministerium Für Inneres, Ländliche Räume und Integration Des Landes Schleswig-Holstein . Gesetz- und Verordnungsblatt für Schleswig-Holstein. (2020). Available at:
https://www.schleswig-holstein.de/DE/landesregierung/ministerien-behoerden/IV/Service/GVOBl/GVOBl/2020/gvobl_7_2020.pdf?__blob=publicationFile&amp;v=3</Citation></Reference><Reference><Citation>Chow EJ, Uyeki TM, Chu HY. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol. (2023) 21:195–210. doi: 10.1038/s41579-022-00807-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00807-9</ArticleId><ArticleId IdType="pmc">PMC9574826</ArticleId><ArticleId IdType="pubmed">36253478</ArticleId></ArticleIdList></Reference><Reference><Citation>Goerlitz L, Dürrwald R, An Der Heiden M, Buchholz U, Preuß U, Prahm K, et al. . Erste Ergebnisse zum Verlauf der Grippewelle in der Saison 2019/20: Mit 11 Wochen vergleichsweise kürzere Dauer und eine moderate Anzahl an Influenza-bedingten Arztbesuchen. (2020). Available at:
https://edoc.rki.de/handle/176904/6627.2</Citation></Reference><Reference><Citation>Buchholz U, Buda S, Prahm K. Abrupter Rückgang der Raten an Atemwegserkrankungen in der deutschen Bevölkerung. (2020). Available at:
https://edoc.rki.de/handle/176904/6601.2</Citation></Reference><Reference><Citation>Goettler D, Niekler P, Liese JG, Streng A. Epidemiology and direct healthcare costs of influenza-associated hospitalizations – nationwide inpatient data (Germany 2010-2019). BMC Public Health. (2022) 22:108. doi: 10.1186/s12889-022-12505-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-022-12505-5</ArticleId><ArticleId IdType="pmc">PMC8761049</ArticleId><ArticleId IdType="pubmed">35033031</ArticleId></ArticleIdList></Reference><Reference><Citation>Pham H, Rahman A, Majidi A, Waterhouse M, Neale RE. Acute respiratory tract infection and 25-Hydroxyvitamin D concentration: a systematic review and meta-analysis. Int J Environ Res Public Health. (2019) 16:3020. doi: 10.3390/ijerph16173020, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph16173020</ArticleId><ArticleId IdType="pmc">PMC6747229</ArticleId><ArticleId IdType="pubmed">31438516</ArticleId></ArticleIdList></Reference><Reference><Citation>Stockwell MS, Reed C, Vargas CY, Wang L, Alba LR, Jia H, et al. . Five-year community surveillance study for acute respiratory infections using text messaging: findings from the MoSAIC study. Clin Infect Dis. (2022) 75:987–95. doi: 10.1093/cid/ciac027, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac027</ArticleId><ArticleId IdType="pmc">PMC9383201</ArticleId><ArticleId IdType="pubmed">35037056</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres A, Cilloniz C, Niederman MS, Menéndez R, Chalmers JD, Wunderink RG, et al. . Pneumonia. Nat Rev Dis Primer. (2021) 7:25. doi: 10.1038/s41572-021-00259-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-021-00259-0</ArticleId><ArticleId IdType="pubmed">33833230</ArticleId></ArticleIdList></Reference><Reference><Citation>Balck A, Föh B, Borsche M, Rahmöller J, Vollstedt EJ, Waldeck F, et al. . Protocol of the Luebeck longitudinal investigation of SARS-CoV-2 infection (ELISA) study - a prospective population-based cohort study. BMC Public Health. (2022) 22:1305. doi: 10.1186/s12889-022-13666-z, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-022-13666-z</ArticleId><ArticleId IdType="pmc">PMC9261226</ArticleId><ArticleId IdType="pubmed">35799167</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein C, Borsche M, Balck A, Föh B, Rahmöller J, Peters E, et al. . One-year surveillance of SARS-CoV-2 transmission of the ELISA cohort: a model for population-based monitoring of infection risk. Sci Adv. (2022) 8:eabm5016. doi: 10.1126/sciadv.abm5016</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abm5016</ArticleId><ArticleId IdType="pmc">PMC9012459</ArticleId><ArticleId IdType="pubmed">35427158</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy C, Lim WW, Mills C, Wong JY, Chen D, Xie Y, et al. . Effectiveness of social distancing measures and lockdowns for reducing transmission of COVID-19 in non-healthcare, community-based settings. Philos Transact A Math Phys Eng Sci. (2023) 381:20230132. doi: 10.1098/rsta.2023.0132, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsta.2023.0132</ArticleId><ArticleId IdType="pmc">PMC10446910</ArticleId><ArticleId IdType="pubmed">37611629</ArticleId></ArticleIdList></Reference><Reference><Citation>Onakpoya IJ, Heneghan CJ, Spencer EA, Brassey J, Plüddemann A, Evans DH, et al. . SARS-CoV-2 and the role of close contact in transmission: a systematic review. F1000Res. (2021) 10:280. doi: 10.12688/f1000research.52439.1</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.52439.1</ArticleId><ArticleId IdType="pmc">PMC9636487</ArticleId><ArticleId IdType="pubmed">36398277</ArticleId></ArticleIdList></Reference><Reference><Citation>Etemad K, Mohseni P, Shojaei S, Mousavi SA, Taherkhani S, Fallah Atatalab F, et al. . Non-pharmacologic interventions in COVID-19 pandemic management; a systematic review. Arch Acad Emerg Med. (2023) 11:e52. doi: 10.22037/aaem.v11i1.1828, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.22037/aaem.v11i1.1828</ArticleId><ArticleId IdType="pmc">PMC10475751</ArticleId><ArticleId IdType="pubmed">37671267</ArticleId></ArticleIdList></Reference><Reference><Citation>Bremer V, An Der Heiden M, Hicketier A. Wirksamkeit und Wirkung von anti-epidemischen Maßnahmen auf die COVID-19-Pandemie in Deutschland (StopptCOVID-Studie). (2023). Available at:
https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Projekte_RKI/StopptCOVID-Bericht.pdf?__blob=publicationFile</Citation></Reference><Reference><Citation>Dürrwald R, Wedde M, Duwe S, Biere B, Reiche J, Köndgen S, et al. . Synopse virologischer Analysen im Nationalen Referenzzentrum für Influenzaviren während der COVID-19-Pandemie. (2022). Available at:
https://edoc.rki.de/handle/176904/9779</Citation></Reference><Reference><Citation>Yan H, Zhai B, Yang F, Wang P, Zhou Y. The impact of non-pharmacological interventions measures against COVID-19 on respiratory virus in preschool children in Henan, China. J Epidemiol Glob Health. (2023) 14:54–62. doi: 10.1007/s44197-023-00168-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s44197-023-00168-3</ArticleId><ArticleId IdType="pmc">PMC11043251</ArticleId><ArticleId IdType="pubmed">38048027</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitanovski S, Horemheb-Rubio G, Adams O, Gärtner B, Lengauer T, Hoffmann D, et al. . Rhinovirus prevalence as indicator for efficacy of measures against SARS-CoV-2. BMC Public Health. (2021) 21:1178. doi: 10.1186/s12889-021-11178-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-021-11178-w</ArticleId><ArticleId IdType="pmc">PMC8215636</ArticleId><ArticleId IdType="pubmed">34154549</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs SE, Lamson DM, St George K, Walsh TJ. Human Rhinoviruses. Clin Microbiol Rev. (2013) 26:135–62. doi: 10.1128/CMR.00077-12, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00077-12</ArticleId><ArticleId IdType="pmc">PMC3553670</ArticleId><ArticleId IdType="pubmed">23297263</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim MC, Park JH, Choi SH, Chung JW. Rhinovirus incidence rates indicate we are tired of non-pharmacological interventions against coronavirus disease 2019. J Korean Med Sci. (2022) 37:e15. doi: 10.3346/jkms.2022.37.e15, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2022.37.e15</ArticleId><ArticleId IdType="pmc">PMC8748668</ArticleId><ArticleId IdType="pubmed">35014227</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu A, Mihaylova VT, Landry ML, Foxman EF. Interference between rhinovirus and influenza a virus: a clinical data analysis and experimental infection study. Lancet Microbe. (2020) 1:e254–62. doi: 10.1016/S2666-5247(20)30114-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30114-2</ArticleId><ArticleId IdType="pmc">PMC7580833</ArticleId><ArticleId IdType="pubmed">33103132</ArticleId></ArticleIdList></Reference><Reference><Citation>Essaidi-Laziosi M, Geiser J, Huang S, Constant S, Kaiser L, Tapparel C. Interferon-dependent and respiratory virus-specific interference in dual infections of airway epithelia. Sci Rep. (2020) 10:10246. doi: 10.1038/s41598-020-66748-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-66748-6</ArticleId><ArticleId IdType="pmc">PMC7314816</ArticleId><ArticleId IdType="pubmed">32581261</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong A, Barrero Guevara LA, Goult E, Briga M, Kramer SC, Kovacevic A, et al. . The interactions of SARS-CoV-2 with cocirculating pathogens: epidemiological implications and current knowledge gaps. PLoS Pathog. (2023) 19:e1011167. doi: 10.1371/journal.ppat.1011167, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1011167</ArticleId><ArticleId IdType="pmc">PMC9994710</ArticleId><ArticleId IdType="pubmed">36888684</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YH, Huang LM, Wang JD. Reduction of acute respiratory illness (ARI) due to a voluntary workplace influenza vaccination program: who are more likely to get the benefit? J Occup Health. (2004) 46:455–60. doi: 10.1539/joh.46.455, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1539/joh.46.455</ArticleId><ArticleId IdType="pubmed">15613768</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltezou HC, Fotiou A, Antonakopoulos N, Kallogriopoulou C, Katerelos P, Dimopoulou A, et al. . Impact of postpartum influenza vaccination of mothers and household contacts in preventing febrile episodes, influenza-like illness, healthcare seeking, and Administration of Antibiotics in young infants during the 2012–2013 influenza season. Clin Infect Dis. (2013) 57:1520–6. doi: 10.1093/cid/cit599, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cit599</ArticleId><ArticleId IdType="pubmed">24046313</ArticleId></ArticleIdList></Reference><Reference><Citation>Le H, de Klerk N, Blyth CC, Gidding H, Fathima P, Moore HC. Non-specific benefit of seasonal influenza vaccine on respiratory syncytial virus-hospitalisations in children: an instrumental variable approach using population-based data. Vaccine. (2023) 41:5029–36. doi: 10.1016/j.vaccine.2023.06.085</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.06.085</ArticleId><ArticleId IdType="pubmed">37407408</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>